Research ArticleClinical Studies
Predicting Survival After Irradiation of Metastases from Transitional Carcinoma of the Bladder
LISA MANIG, LUKAS KÄSMANN, STEFAN JANSSEN and DIRK RADES
Anticancer Research December 2016, 36 (12) 6663-6665;
LISA MANIG
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
LUKAS KÄSMANN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
STEFAN JANSSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
2Private Practice of Radiation Oncology, Hannover, Germany
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
In this issue
Anticancer Research
Vol. 36, Issue 12
December 2016
Predicting Survival After Irradiation of Metastases from Transitional Carcinoma of the Bladder
LISA MANIG, LUKAS KÄSMANN, STEFAN JANSSEN, DIRK RADES
Anticancer Research Dec 2016, 36 (12) 6663-6665;
Jump to section
Related Articles
- No related articles found.
Cited By...
- A New Prognostic Tool for Patients Undergoing Radiotherapy plus Upfront Transurethral Resection for Bladder Cancer
- Factors Impacting the Overall Survival of Patients Irradiated for Invasive Carcinoma of the Urinary Bladder
- Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer
- Concurrent Chemotherapy Improves the Overall Survival of Patients Irradiated for Locally Recurrent Bladder Cancer
- A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder Cancer